Phase I study of PTG-200 for the treatment of Crohn's disease.
Phase of Trial: Phase I
Latest Information Update: 04 May 2017
At a glance
- Drugs PTG 200 (Primary)
- Indications Crohn's disease
- Focus Adverse reactions
- 04 May 2017 According to a Protagonist Therapeutics media release, this trial is expected to begin in the second half of 2017.
- 24 Nov 2016 New trial record
- 14 Nov 2016 According to a Protagonist media release, the company plans to initiate this study in 2017.